OncLive: Dr. Mesa on recent data with momelotinib in MPNs and myelofibrosis

July 20, 2020

Ruben Mesa, MD, director of the Mays Cancer Center, discusses recent data with momelotinib in myelofibrosis. Read and watch the story.

Study hints at novel therapeutic target for Ewing sarcoma

July 16, 2020

New insights into Ewing sarcoma, an aggressive childhood cancer, were published July 15 in the prestigious journal Nature.

The Cancer Letter: Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio

July 13, 2020

Dr. Ruben Mesa, Mays Cancer Center Director, contributes to The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology. Read the story.

Ivanhoe Broadcast News: Cork tree bark to fight prostate cancer

July 6, 2020

Darpan Patel, PhD, a faculty member in the School of Nursing, and Pratap Kumar, PhD, in the Department of Molecular Medicine, explain why cork tree bark, an herbal remedy that’s been around for centuries, is being studied as a way to shrink prostate tumors.

When it comes to DNA repair, it’s not one tool fits all

June 26, 2020

Our cells are constantly dividing, and as they do, the DNA molecule – our genetic code – sometimes gets broken. DNA has twin strands, and a break in both is considered especially dangerous. This kind of double-strand break can lead to genome rearrangements that are hallmarks of cancer cells, said James Daley, PhD, of the […]

A message to patients from Ruben Mesa, MD, director of Mays Cancer Center

June 23, 2020

In this video message, Ruben Mesa, MD, director of the Mays Cancer Center, reassures patients that their safety is a top priority during this uncertain time due to the COVID-19 pandemic.